Imatinib treatment: Specific issues related to safety, fertility, and pregnancy-Reference-Cited by-同舟云学术

Imatinib treatment: Specific issues related to safety, fertility, and pregnancy

Published:2003-04 Issue: Volume:40 Page:21-25
ISSN:0037-1963
Container-title:Seminars in Hematology
language:en
Short-container-title:Seminars in Hematology

Author:

Hensley Martee L.,Ford John M.

Publisher

Elsevier BV

Subject

Hematology

Reference10 articles.

1. Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-Kit and platelet-derived growth factor receptors;Buchdunger;J Pharmacol Exp Ther,2000

2. Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phinylaminopyrimidine derivative;Buchdunger;Cancer Res,1996

3. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia;O'Brien;N Engl J Med,2003

4. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome;Druker;N Engl J Med,2001

5. Clinical efficacy and safety of an abl-specific tyrosine kinase inhibitor as targeted therapy for chronic myeloid leukemia;Druker;N Engl J Med,2001

Cited by 149 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Insights of Target Therapy: Effects of Tyrosine Kinase Inhibitors on Male Gonadal Function: A Systematic Review;Clinical Genitourinary Cancer;2024-10

2. Evaluation of contraception methods in chronic myeloid leukemia patients: A Turkish multicenter study;Journal of Oncology Pharmacy Practice;2024-09-02

3. Synthesis and application of small molecules approved for the treatment of lymphoma;European Journal of Medicinal Chemistry;2023-12

4. Fertility and pregnancy in chronic myeloid leukemia: real-world experience from an Indian tertiary care institution;Annals of Hematology;2023-06-15

5. Managing women of childbearing age with chronic myeloid leukemia: safety and treatment considerations;Expert Review of Hematology;2023-04-20